CandlesenseCandlesense
CSTLPartnership•globenewswire•

Castle Biosciences Enters Collaboration and License Agreement with SciBase to Develop Diagnostic Tests for Dermatologic Diseases

Sentiment:Neutral (50)

Summary

Castle Biosciences, Inc. today announced that it has entered entered into a collaboration and license agreement with SciBase Holding AB.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on June 16, 2025 by globenewswire

← Back to CSTL News
    Castle Biosciences Enters Collaboration and License Agreement with SciBase to Develop Diagnostic Tests for Dermatologic Diseases | CSTL Stock News | Candlesense